Literature DB >> 16650844

A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms.

Doris Hofer1, Birgit Lohberger, Bibiane Steinecker, Kurt Schmidt, Stefan Quasthoff, Wolfgang Schreibmayer.   

Abstract

The specific, acute interaction of tolperisone, an agent used as a muscle relaxant and for the treatment of chronic pain conditions, with the Na(v1.2), Na(v1.3), Na(v1.4), Na(v1.5), Na(v1.6), Na(v1.7), and Na(v1.8) isoforms of voltage dependent sodium channels was investigated and compared to that of lidocaine. Voltage dependent sodium channels were expressed in the Xenopus laevis oocyte expression system and sodium currents were recorded with the two electrode voltage clamp technique. Cumulative dose response relations revealed marked differences in IC(50) values between the two drugs on identical isoforms, as well as between isoforms. A detailed kinetic analysis uncovered that tolperisone as well as lidocaine exhibited their blocking action not only via state dependent association/dissociation with voltage dependent sodium channels, but a considerable fraction of inhibition is tonic, i.e. permanent and basic in nature. Voltage dependent activation was affected to a minor extent only. A shift in steady-state inactivation to more negative potentials could be observed for most drug/isoform combinations. The contribution of this shift to overall block was, however, small at drug concentrations resulting in considerable overall block. Recovery from inactivation was affected notably by both drugs. Lidocaine application led to a pronounced prolongation of the time constant of the fast recovery process for the Na(v1.3), Na(v1.5), and Na(v1.7) isoforms, indicating common structural properties in the local anesthetic receptor site of these three proteins. Interestingly, this characteristic drug action was not observed for tolperisone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650844     DOI: 10.1016/j.ejphar.2006.03.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Subunit stoichiometry of heterologously expressed G-protein activated inwardly rectifying potassium channels analysed by fluorescence intensity ratio measurement.

Authors:  E Grasser; B Steinecker; H Ahammer; W Schreibmayer
Journal:  Pflugers Arch       Date:  2007-10-17       Impact factor: 3.657

2.  Comparative effects of halogenated inhaled anesthetics on voltage-gated Na+ channel function.

Authors:  Wei Ouyang; Karl F Herold; Hugh C Hemmings
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

Review 3.  Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.

Authors:  Stefan Quasthoff; Claudia Möckel; Walter Zieglgänsberger; Wolfgang Schreibmayer
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

4.  Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.

Authors:  Nicholas V Cozzi; Simon D Brandt; Paul F Daley; John S Partilla; Richard B Rothman; Andreas Tulzer; Harald H Sitte; Michael H Baumann
Journal:  Eur J Pharmacol       Date:  2012-11-21       Impact factor: 4.432

5.  Modelling of an autonomous Nav1.5 channel system as a part of in silico pharmacology study.

Authors:  Alexey Rayevsky; Dariia O Samofalova; Oleksandr Maximyuk; Maxim Platonov; Vasyl Hurmach; Sergey Ryabukhin; Dmitriy Volochnyuk
Journal:  J Mol Model       Date:  2021-05-24       Impact factor: 1.810

6.  Four and a half LIM protein 1C (FHL1C): a binding partner for voltage-gated potassium channel K(v1.5).

Authors:  Ivana Poparic; Wolfgang Schreibmayer; Benedikt Schoser; Gernot Desoye; Astrid Gorischek; Heidi Miedl; Sonja Hochmeister; Josepha Binder; Stefan Quasthoff; Klaus Wagner; Christian Windpassinger; Ernst Malle
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

7.  Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant.

Authors:  Kornelia Tekes
Journal:  Open Med Chem J       Date:  2014-07-11

8.  The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action.

Authors:  Péter P Lakatos; Dávid Árpád Karádi; Anna Rita Galambos; Nariman Essmat; Kornél Király; Rudolf Laufer; Orsolya Geda; Zoltán S Zádori; Tamás Tábi; Mahmoud Al-Khrasani; Éva Szökő
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

9.  Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms.

Authors:  Thummala Veera Raghava Raju; Raja Kumar Seshadri; Srinivas Arutla; Tharlapu Satya Sankarsana Jagan Mohan; Ivaturi Mrutyunjaya Rao; Someswara Rao Nittala
Journal:  Sci Pharm       Date:  2012-11-05

10.  Molecular basis of the facilitation of the heterooligomeric GIRK1/GIRK4 complex by cAMP dependent protein kinase.

Authors:  Fritz Treiber; Christian Rosker; Tal Keren-Raifman; Bibiane Steinecker; Astrid Gorischek; Nathan Dascal; Wolfgang Schreibmayer
Journal:  Biochim Biophys Acta       Date:  2013-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.